Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The EVOLVE Study: A Prospective, Observational Study to Evaluate Patient-centered Outcomes Over 2 Years of Treatment With Tezepelumab in Real-life Clinical Practice in Greece

NCT06724575 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06724575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06724575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The EVOLVE Study: A Prospective, Observational Study to Evaluate Patient-centered Outcomes Over 2 Years of Treatment With Tezepelumab in Real-life Clinical Practice in Greece
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
December 17, 2024
Completion date
June 30, 2028
Enrollment
156 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

asthma